S
ignaling through the TCR initiates a cascade of phosphorylation events that leads to T cell activation. Until recently, the strength of the TCR and costimulatory signals was considered to be the major regulator of T cell activity. However, NK cell-associated inhibitory receptors (NK-IRs) 2 that recruit phosphatases to their cytoplasmic immunoreceptor tyrosinebased inhibitory motifs (ITIMs) also influence CD8 T cell function (reviewed in Ref. 1) . Two classes of NK-IRs exist in humans and mice: type I membrane proteins that belong to the Ig superfamily, such as the killer cell Ig-like receptors (KIRs) and leukocyte Iglike receptors/Ig-like transcripts/leukocyte-associated Ig-like receptors in humans, and gp49B1 in mice; and type II membrane proteins that have homology to C-type lectins, such as the CD94/NKG2 receptors in humans and mice and the Ly49 receptors in mice (2) .
A number of studies have shown that KIRs are expressed by memory/effector CTL under conditions of chronic Ag stimulation, such as tumors and HIV infection, leading to the view that the NK-IRs perhaps serve to reduce CTL-mediated immunopathology after protracted antigenic stimulation (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Although these studies authenticate that CTL can express NK-IRs under certain situations, their role in a primary immune response in vivo was not clear. Recently, using a polyoma infection model in mice, Moser et al. (13) demonstrated that the NK-IR, CD94-NKG2A, downregulates the CTL response during viral clearance and virus-induced oncogenesis. Other studies in mice also suggest that several NK-IRs can be expressed during acute viral infection, but some reports have questioned the role of such receptors (14 -17) .
Two related transmembrane members of the gp49 family, gp49A and gp49B1, are expressed constitutively in mast cells and are induced in NK cells after murine CMV infection (18 -20) . Although highly homologous to gp49B1 (88% overall amino acid identity), gp49A has a much shorter cytoplasmic domain, lacks the two ITIMs present in gp49B1, and activates mast cells when crosslinked by Ab (18, 19, 21) . gp49B1 inhibits mast cell activation in vitro by recruiting Src homology protein-1 when co-cross-linked with Fc⑀RI (22) . Moreover, mast cells in gp49B1-deficient mice exhibit increased sensitivity to Fc⑀RI-dependent mast cell activation that leads to greater tissue inflammation (23) . gp49B1 also inhibits NK1.1-mediated cytokine release from NK cells when cocross-linked with the stimulatory NK1.1 mAb (20) . Whereas the lectin-like CD94-NKG2 and LY49 receptors have been reported to be expressed by CTL in mice, expression of gp49 in T cells remains unexplored.
We have previously reported that distinct populations of effector and memory CTL can be generated from Ag-primed CD8 T cells in vitro by varying the cytokine milieu (24) . We further found by gene chip analysis, that gp49A/B1 is one of the genes expressed selectively in effector CTL (our unpublished data). Therefore, we have defined the expression of gp49A/B1 in effector T cells and determined its function by comparing normal and gp49B1-deficient mice. We found that gp49B1 is expressed in effector cells of both the CD4 and CD8 T cell lineages and serves to selectively control cytokine secretion function.
Materials and Methods

Mice
P14 TCR Tg mice (25) , expressing the transgenic TCR specific for the lymphocytic choriomeningitis virus (LCMV) gp33-41 peptide in the C57BL/6 background were the kind gift of Dr. R. Ahmed (Emory University, Atlanta, GA). Male gp49B1 Ϫ/Ϫ mice (23) backcrossed into the C57BL/6 background for six generations and their gp49 ϩ/ϩ littermate controls bred in parallel, were used at 6 -10 wk of age for the experiments. C57BL/6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Mice were maintained under viral Ag-free/specific pathogen-free conditions in microisolator cages.
Peptide stimulation
To generate effector CTL in vitro, splenocytes from P14 mice were stimulated with 5 g/ml gp33-41 peptide, KAVYNFATC (synthesized at BioSource International, Camarillo, CA) and cultured in 20 ng/ml IL-2 for 7 days as described previously (24) . After 7 days of culture, Ͼ95% of viable cells are CD8 T cells (24) .
Viral, bacterial, and allogeneic tumor challenge
gp49B1-deficient mice and their littermate controls, backcrossed (N6) to C57BL/6 background, were infected by i.p. injection with either the WR strain of vaccinia virus (10 6 PFU/mouse in 200 l PBS), 10 4 CFU of Listeria monocytogenes (LM), or 5 ϫ 10 6 mastocytoma cell line, P815 (H-2 d ), and at indicated times postinfection, their peritoneal exudate lymphocytes (PEL), spleen, and ovaries were harvested.
Flow cytometry
For phenotypic analyses, splenocytes from P14 TCR Tg mice and PEL and splenocytes from normal and gp49B1-deficient mice were stained with anti-mouse CD8-Cy5, CD4-FITC, and PE-labeled Abs to mouse CD62L, CD69, CD44, CD25, or CD43 (1B11) (BD PharMingen, San Diego, CA). All samples were analyzed on a FACScan flow cytometer (BD Biosciences, Mountain View, CA). gp49A/B1 expression was measured using the hamster IgG monoclonal, H1.1, that recognizes both gp49A and gp49B1 (20) , followed by biotin-labeled goat anti-hamster Ig and streptavidin-PE. To test gp49A-and gp49B1-specific expression, cells were stained with either the rat IgM monoclonal B23.1 (26) , specific for gp49B1, followed by FITC-labeled goat anti-rat IgM, or with the rabbit polyclonal Ab raised against the gp49A201-216 peptide (19) followed by FITC-labeled anti-rabbit IgG. Isotype controls included syrian hamster IgG, rat IgM, and rabbit IgG Abs (Jackson ImmunoResearch Laboratories, West Grove, PA).
Intracellular IFN-␥, cytotoxicity, and lymphocyte proliferation assays
These assays have been described previously (24) . Briefly, to detect IFN-␥ production, 0.5 ϫ 10 6 peptide-stimulated P14 splenocytes or PEL from vaccinia-infected mice were stimulated with either gp33-41 peptidepulsed EL-4 cells or vaccinia virus-infected (10 PFU/cell, overnight) adherent macrophages from wild-type C57BL/6 mice (elicited 3 days after ip injection of 1% thioglycolate broth), or anti-CD3 (at indicated concentrations) in the presence of 1 M Golgi stop. Non-peptide-pulsed and uninfected EL-4 cells served as controls. After 6 -8 h of incubation, the cells were stained with Cy5-labeled anti-CD8, FITC-labeled anti-CD4, or FITClabeled NK1.1 Ab (BD PharMingen); fixed; permeabilized; and stained with PE-labeled anti-mouse IFN-␥ Ab.
Peptide stimulated P14 T cells were tested for lysis of 51 Cr-labeled EL-4 (H-2 b ) target cells unpulsed or pulsed with 10 g/ml gp33-41 peptide in a 4-h chromium release assay. To test anti-viral cytotoxicity, 51 Cr-labeled, uninfected or vaccinia virus-infected (10 PFU/cell, overnight) EL-4 cells were used at targets. Background cytotoxicity of non-peptide-pulsed EL-4 cells or uninfected EL-4 cells (always Ͻ5%) was subtracted to calculate peptide and viral-specific cytotoxicity. NK cell cytotoxicity was similarly tested using 51 Cr-labeled Yac-1 cells.
RT-PCR
RT-PCR was performed on RNA extracted from peptide stimulated P14 splenocytes using gp49A and gp49B1-specific upstream primers and the common downstream primer as described earlier (19) .
Measurement of virus titers
Ovaries were harvested from vaccinia-infected mice and homogenized. Viral titers were determined by serial 10-fold dilutions using CV-1 cells as described (27) .
Results
gp49B1 is induced in Ag-specific CD8 T cells coordinately with development of effector functions
CD8 T cells from P14 mice express a transgenic TCR specific for the LCMV glycoprotein epitope, gp33-41 (25) . When stimulated with the cognate peptide and cultured in the presence of 20 ng/ml rIL-2, the Tg CD8 T cells differentiate over 4 -6 days into cells that exhibit all features of effector CTL, including the effectorspecific phenotype and high levels of cytotoxicity (24) . We used this system to study the kinetics of gp49A/B1 expression vis-à-vis the development of effector functions. Peptide stimulated P14 splenocytes were tested every 2 days until 10 days poststimulation for the binding of mAb H1.1 that recognizes both gp49A and gp49B1 (20) . The cells were also tested in parallel for peptidespecific cytotoxicity and IFN-␥ production. As Fig. 1 shows, unstimulated naive CD8 T cells were uniformly negative for gp49A/B1 expression and did not exhibit cytotoxicity or produce IFN-␥. gp49A/B1 expression progressively increased after peptide stimulation and nearly all CD8 T cells expressed high levels of gp49A/B1 6 -8 days after stimulation. The increasing levels of gp49A/B1 expression paralleled the progressive increase in Agspecific IFN-␥ producing and cytotoxic functions, suggesting that gp49A/B1 may be specifically expressed by CD8 T cells with capacity for immediate effector functions. We have recently reported that while IL-2 progressively promotes the development of effector phenotype and functions in Ag-stimulated CD8 T cells, IL-15 tends to reverse the process (24) . Thus, to test whether gp49A/B1 expression also decreases in IL-15-treated cells, we treated day 5 IL-2-differentiated effector cells with IL-15 for 5 days and tested them along with cells continually maintained in IL-2 for effector functions. While gp49A/B1 expression progressively increased in cells maintained continuously in IL-2 ( Fig. 1 , day 10), gp49A/B1 expression and effector functions did not increase in IL-15 treated cells ( Fig. 1 , filled bars). Compared with cells continually maintained in IL-2, the IL-15-switched cells showed dramatically reduced mean fluorescent intensity (MFI) for both IFN-␥ and gp49A/B1 staining (there was also an ϳ20% reduction in the number of positive cells). Because gp49A is a stimulatory receptor and gp49B1 is an inhibitory receptor, we also stained the cells on poststimulation day 8 (when they had high levels of gp49A/B1) with a rabbit polyclonal Ab that is gp49A-specific and the rat monoclonal, B23.1, which is gp49B1-specific (20, 26) . Specific binding was seen with gp49B1-specific Ab (Fig. 1, bottom panel) . The staining intensity of gp49B1-specific monoclonal, B23.1 is lower compared with gp49A/B1-specific H1.1 monoclonal probably because, a two-step staining procedure (with FITC-labeled second step reagent) was used for B23.1 whereas a three-step staining (with streptavidin PE as a third step reagent) was used for H1.1. However, no staining above isotype control was seen with gp49A-specific Ab. Thus, the inhibitory gp49B1, but not the stimulatory gp49A is expressed by effector CD8 T cells. These results were also confirmed by RT-PCR using gp49A-and gp49B1-specific primers (data not shown). Collectively, these results suggest that gp49 B1 expression closely parallels effector potential, raising the possibility that gp49 B1 may regulate effector responses.
gp49B1 is expressed by both CD8 and CD4 effector T cells in vivo, and its expression subsides in memory cells
To test whether gp49B1 is also expressed in an effector-specific manner in vivo, we tested naive, effector, and memory T cells after vaccinia infection. We have previously reported that T cells accumulating in the peritoneal cavity 7 days after i.p. infection with vaccinia virus are highly enriched for effector T cells (28) . Thus, to determine whether gp49A/B1 is induced in Ag-specific T cells after infection, we compared naive T cells from uninfected mice, T cells accumulating in the PEL, as well as the splenic T cells harvested 7 days after infection, for effector phenotype and gp49A/B1 expression. It has previously been shown that the isoform of CD43 recognized by the mAb, 1B11 is specifically expressed by Ag-specific effector T cells, but not by naive or memory T cells (29) . Because MHC-peptide tetramers are not available for vaccinia virus, we used CD62L and 1B11 staining to identify Agspecific T cells. Naive T cells in the spleen from uninfected mice uniformly expressed CD62-L, but did not express gp49A/B1 or the 1B11 epitope. In infected mice, over 90% of T cells in PEL and ϳ50% T cells in the spleen down-regulated L-selectin and upregulated the expression of the 1B11 epitope of CD43. A corresponding percentage of T cells in the PEL and spleen also expressed high levels of gp49A/B1 (Fig. 2) , suggesting that gp49A/B1 is expressed selectively in effector T cells. Similar to in vitro generated CTL, gp49A/B1 expression as well as L-selectin down regulation and 1B11 up-regulation progressively increased between days 4 -8 after infection (data not shown).
It has been reported that the CD94-NKG2 receptor is expressed for long periods after Ag stimulation (13) . Thus, we tested whether long-term memory T cells generated in vivo retain gp49A/B1 expression. To generate memory T cells, we infected C57BL/6 mice with vaccinia virus, rested them for 10 wk, and stained them with CD44 and H1.1 mAbs. Compared with uninfected mice, splenocytes from infected mice had higher levels of CD44 high T cells (36 Ϯ 5% vs 20 Ϯ 7%, n ϭ 4), suggesting that the expansion was because of memory cells generated as a consequence of vaccinia infection. The CD44 high CD4 and CD8 T cells expressed barely detectable levels of gp49A/B1 (Fig. 2) . The splenocytes from these mice did not exhibit detectable anti-vaccinia cytotoxicity although they were capable of viral-specific proliferation in vitro (data not shown). Collectively our results suggest that gp49A/B1 expression parallels the rise in functional capability and decreases in memory T cells.
To determine whether gp49A and/or gp49B1 is up-regulated in vivo, we stained PEL from gp49B1 ϩ/ϩ and gp49B1 Ϫ/Ϫ mice harvested 7 days after vaccinia infection with H1.1 mAb, gp49A-specific, and gp49B1-specific Abs (20, 26) . CD8 T cells from gp49B1 ϩ/ϩ mice stained with the H1.1 and gp49B1-specific Ab, but exhibited no staining with gp49A-specific Ab (Fig. 3 ). In contrast, CD8 T cells from gp49B1-deficient mice did not stain with any of the Abs. Similar results were also obtained with CD4 T cells (data not shown). 
gp49B1 is also expressed by CD8 and CD4 T cells after LM and P815 allogeneic tumor challenge
To determine whether gp49B1 expression is a common characteristic of all activated T cells, we infected C57BL/6 mice i.p. with LM or injected allogeneic P815 (H2 d ) cells and tested the CD4 and CD8 T cells in PEL 10 days after challenge for binding H1.1 mAb. As Fig. 4 shows, a high level binding of H1.1 was seen in CD4 and CD8 T cells after both methods of challenge. These cells were effector cells because they were uniformly CD62L Ϫ , CD44 high and 1B11 high (data not shown). The gp49 protein expressed was also confirmed to be gp49B1 using the gp49A-and gp49B1-specific Abs (data not shown). Thus, gp49B1 expression is not unique to vaccinia infection, but defines Ag-activated T cells.
gp49B1 negatively regulates IFN-␥ production by CD8 T cells, CD4 T cells, and NK cells
The specific expression of ITIM bearing gp49B1 in the effector phase of immune response suggested that it might function to dampen the T cell effector functions. To ascertain whether this is indeed the case, we infected gp49B1 Ϫ/Ϫ mice and their gp49 ϩ/ϩ littermate controls backcrossed into the C57BL/6 background for six generations, with vaccinia virus i.p. and examined their T cells accumulating in PEL 7 days later for their phenotype and function. There were no significant differences between gp49B1 ϩ/ϩ and gp49B1 Ϫ/Ϫ mice in the expression of CD62L, CD25, CD69, CD44, or the effector isoform of CD43, suggesting that gp49B1 does not affect priming and activation of T cells (data not shown). To test functionality, we measured viral-specific IFN-␥ production and viral-specific cytotoxicity 7 days after infection. To be able to measure IFN-␥ production by both CD8 and CD4 T cells, we used syngeneic macrophages derived from uninfected wild-type C57 mice as targets (since they express both class I and class II molecules). Viral-specific cytotoxicity was measured using EL-4 cell targets. Because gp49B1 is also expressed by NK cells after virus infection, we also measured Ag-independent IFN-␥ producing and cytotoxic functions of NK cells accumulating in PEL 3 days after vaccinia infection using the NK cell sensitive target, Yac-1 cells. As shown in Fig. 5 , IFN-␥ responses of all subsets of cells were enhanced in gp49B1-deficient mice compared with gp49 ϩ/ϩ mice. Although a small increase in cytotoxicity was detectable, they were not statistically significant. Collectively, these results suggest that gp49B1 selectively inhibits IFN-␥ response of Ag-specific CD8 T cells, CD4 T cells, and NK cells. 
PELs from vaccinia-infected gp49
ϩ/ϩ (wild type (WT)) and gp49B1-deficient mice (knockout (KO)) harvested on day 7 postinfection were stained with anti-CD8 and the hamster mAb H1.1 (recognizes both gp49A and gp49B1), or rabbit anti-gp49A 201-216 polyclonal (specific for gp49A) or the rat mAb B23.1 (specific for gp49B1) and examined by flow cytometry. In the overlay histograms, the open histograms represent staining with isotype controls. Results are representative of two experiments. 
gp49B1 increases effector cell activation threshold
It has been suggested that NK-IRs regulate T cell responses by increasing their threshold for stimulation. If this is true for gp49B1, the stimulation threshold should be less for effector T cells from gp49B1-deficient mice. Indeed the threshold for IgE ϩ Ag-induced activation of mast cells in vivo is ϳ10-fold lower in gp49B1-deficient mice (23) . Therefore, we stimulated PELs from vaccinia-infected wild-type and gp49B1-deficient mice with graded doses of soluble anti-CD3 Ab (to allow presentation by macrophage FcR) and measured their IFN-␥ production. While no differences were seen with anti-CD3 Ͼ10 ng/ml, at concentrations of 1 and 0.1 ng/ml, few wild-type T cells responded, whereas a fraction (5-10%) of gp49B1-deficient T cells produced IFN-␥ (Fig. 6 ). Collectively our results suggest that gp49B1 serves to negatively regulate IFN-␥ production by effector cells by increasing their activation threshold.
Discussion
Although members of the lectin family of NK-IRs, such as CD94/ NKG2A heterodimer and killer cell lectin-like receptor G1 (KLRG1), are expressed by murine Ag-specifc CD8 T cells during an acute viral infection (16, 17) , the Ig superfamily members are not known to be expressed on T cells. We demonstrate in this work that the Ig superfamily member, gp49B1 is expressed by nearly all Ag-activated CD8 as well as CD4 T cells responding to a viral or bacterial Ag. We also show that gp49B1 inhibits IFN-␥ production by CD4 T cells, CD8 T cells, and NK cells following acute infection without affecting the cytotoxic function.
Our results using a number of different models of antigenic stimulation indicate that gp49B1 expression is a common feature of activated Ag-specific T cells. However, Wang et al. (20) failed to detect gp49A/B1 expression on T cells after infection with murine CMV. Probably because the focus of their study was on NK cells, they only examined splenocytes 3 days after infection, at which ϩ/ϩ (wild type (WT)) and gp49B1 (knockout (KO)) mice were infected with vaccinia virus and the peritoneal exudate cells harvested on day 3 (for NK cells) or day 7 (for CD8 and CD4 T cells) postinfection were tested for IFN-␥ production and cytotoxicity. To measure IFN-␥ production, the cells were stimulated for 6 h with vaccinia virus-infected adherent macrophages from wild-type mice (for CD4 and CD8 T cells) or Yac-1 cells (for NK cells), stained externally with anti-CD8 and anti-CD4 or NK1.1 mAb and intracellularly with anti-IFN-␥ Ab. Representative dot plot analyses are shown in the top panel. Bar graphs in the middle panel show data from six mice (from two experiments) in each category as mean values Ϯ SD. In each bar graph except the one that shows IFN-␥ MFI, the difference is statistically significant (two independent experiments with three mice of each genotype per experiment; p Ͻ 0.05, paired two-tailed Student's t test). To measure cytotoxic function, (lower panel), the peritoneal exudates cells were tested for specific lysis of vaccinia-infected EL-4 targets (anti-viral cytotoxicity) or Yac-1 targets (NK cytotoxicity) in a 4-h chromium release assay.
FIGURE 6.
Stimulation threshold for IFN-␥ production decreases in the absence of gp49B1. PEL from day 7 vaccinia-infected gp49 ϩ/ϩ (wild type (WT)) and gp49 Ϫ/Ϫ (knockout (KO)) mice were stimulated with indicated concentrations of soluble anti-CD3 Ab for 6 h and intracellular IFN-␥ production was measured as described in Fig. 1 . Data are shown as the mean of three animals in each group Ϯ SD. The differences seen at anti-CD3 concentrations of 1 and 0.1 ng/ml are statistically significant (p Ͻ 0.05, paired two-tailed Student's t test). No differences were seen at anti-CD3 doses Ͼ10 ng/ml (not shown).
time, the spleen is unlikely to harbor a sufficient number of Agspecific T cells (30) . Moreover, our kinetics data also suggest that maximal expression of gp49B1 requires 4 -5 days of stimulation. Thus, it is unlikely that gp49B1 is not expressed by CMV-specific T cells.
It is remarkable that gp49B1 with inhibitory potential, but not the closely related gp49A, lacking the cytoplasmic ITIM is expressed in T cells, perhaps reflecting a strong need for such regulation in T cells. However, both receptors are expressed in mast cells (19) . The fact that gp49B1 is constitutively expressed in mast cells, but has to be induced in T cells by activation suggest differential transcription factor usage in these cell types. Based on coordinate expression of gp49A and gp49B1 on mast cells and their chromosomal localization to within 4.5 kb of each other, it has been postulated that these two molecules may be coordinately regulated in mast cells (19) . Our results suggest that this is not the case in T cells and that they are differentially regulated at a transcriptional level.
The kinetics of gp49B1 expression in activated T cells as well as the fact that gp49B1 expression decreased in memory cells suggest that gp49B1 serves to restrain T cells when they have maximal functional capacity during an acute viral infection. In contrast, the Ig family KIRs have been generally thought to be expressed as a result of chronic, rather than acute stimulation since they are expressed in tumors and HIV infection but not after superantigen stimulation or acute infections (6, 12, 17, 31) . These differences indicate that NK-IRs may not be redundant, but may control T cell functions at different time points during an immune response.
The lectin-like Ly49 family of receptors in mice behave biologically like the Ig family of KIRs in humans (reviewed in Refs. 1 and 2). Both groups encode numerous NK cell receptors specific for different classical MHC class I molecules, and are expressed by a fraction of CD8 T cells in a variegated, overlapping fashion, so that individual cells typically express a distinct subset of receptors. Although KIR and Ly49 ϩ CD8 T cells specific for tumor or viral Ags can be isolated, the majority of CTLs specific for a given Ag do not express these receptors, nor are these receptors induced after acute viral infection in humans or in mice (32, 33) . In contrast, the lectin-like receptor, CD94-NKG2, recognizes the nonclassical MHC molecule, HLA E (in humans) or Qa1 (in mice) complexed with peptides derived from MHC molecules and is induced in the vast majority of Ag-specific CD8 T cells during acute viral infections (13, 16, 17) . Similarly, the lectin family of NK receptors with unknown ligands like NK1.1 and KLRG1 are also expressed in a majority of Ag-specific CD8 T cells after viral infection in mice (15, 16) . Our results show that gp49B1, although it belongs to the Ig family, behaves like the lectin receptors CD94-NKG2A and KLRG1, because it is induced on the vast majority of CD8 T cells after antigenic stimulation. Thus, the structural classification into lectin and Ig family may not be indicative of biologic role and underscores a need for function/biology-based classification.
Inhibition of cytokine release by gp49B1 when cross engaged with stimulatory receptors has been demonstrated in NK cells in vitro (20) . Our results with T cells are in accordance with these studies and further suggests that the cytokine production, but not the cytotoxic functions are affected by gp49B1. Similar dichotomy in regulating cytotoxic and cytokine production functions has been reported in NK cells for the stimulatory receptors, KIR2DL4 and 2B4 (34) . When stimulated with a mAb for KIR2DL4, resting NK cells readily secreted IFN-␥, but were unable to lyse target cells and in contrast, 2B4 mAb stimulated cytotoxicity but not IFN-␥ production. Moreover, inhibition of multiple steps in MAPK signaling abrogated cytotoxicity in the human NK cell line, YT, whereas IFN-␥ production could only be inhibited using specific inhibitors of p38, suggesting that different signaling pathways may be involved in cytotoxicity and cytokine release (35) . Unlike other NK-IRs, which recognize MHC molecules, gp49B1 has been reported to bind the integrin ␣ V ␤ 3 (36) . Although it is not known whether this is the sole or the principal ligand for gp49B1 on T cells, one possible explanation for the dichotomy we observed is that we used the ligandexpressing macrophages to present Ags or CD3 Ab for the IFN-␥ assays and the ligand-negative EL-4 cells for the cytotoxicity assays. However, this seems unlikely because we were unable to detect significant differences in cytotoxicity even using the ␣ V ␤ 3 expressing syngeneic lung fibroblasts as targets (data not shown). Thus, it is possible that gp49B1-generated signals could particularly affect the pathways involved in IFN-␥ production.
What might be the benefit of gp49B1-mediated inhibition of T and NK cell cytokine secretion during an acute infection? Several reasons have been proposed for the existence of inhibitory receptors. One view is that inhibitory receptor expression represents a mechanism to avoid over-stimulation that would otherwise lead to tissue damage, exhaustion, or activation-induced cell death (AICD) (12, 37) . Forced expression of the inhibitory receptor Ly49A in transgenic mice resulted in increased LCMV titers (37) . However, we did not observe significant differences in viral titers or obvious signs of tissue destruction in gp49B1 Ϫ/Ϫ mice during acute vaccinia infection (data not shown). It may be that this could be more important in protracted infections. Another possibility is that gp49B1 may selectively impair the activation and expansion of T cells with low affinity TCR, thereby playing a role in determining the immunodominance of the response. Such a role for an inhibitory receptor has been shown in LY49 transgenic mice, where CTLs specific for a subdominant LCMV epitope were inhibited more strongly than those specific for dominant epitopes (37) . Studies are underway to determine whether gp49B1 is involved in shaping immunodominance of the T cell response.
Based on the finding of KIR ϩ CTL clones specific for self Ags from melanoma patients as well as from healthy individuals, it has been proposed that inhibitory receptors may prevent auto aggression by CTLs specific for self Ag (4, 6, 38) . Moreover, when the Ly49A transgene was expressed on T cells and thymocytes, the mice developed a fatal inflammatory disease suggestive of autoimmunity, possibly due to a failure to delete autoreactive T cells (39, 40) . gp49B1, by raising the activation threshold of effector cells, might inhibit responses to cells that present low affinity, cross-reactive self peptides. In this context, it is noteworthy that cross-reactive CTL have been demonstrated following a number of viral infections (41, 42) . Although gp49B Ϫ/Ϫ mice do not develop spontaneous autoimmunity, it will be interesting to test their proclivity to autoimmunity in experimental models.
It has also been proposed that NK-IRs may facilitate memory cell generation by inhibiting AICD of effector cells. Large numbers of memory phenotype CD8 T cells accumulate in transgenic mice expressing human KIR2DL3 and its ligand, HLA-Cw3 (43) . Moreover, in vitro recognition of HLA-Cw3 down-regulates AICD of KIR2DL3-expressing CD8 T cells. Similarly, KIR ϩ rather than KIR Ϫ CD8 T cells in humans were capable of surviving in vitro cloning and were resistant to AICD (44) . However, we did not observe overt differences between wild-type and gp49B1-deficient mice in the total number of memory phenotype (CD44 high ) T cells 2 mo after vaccinia infection.
In summary, our results provide evidence that gp49B1 is a unique NK-IR that can regulate the cytokine secretion functions of multiple lineages of effector cells in vivo. Further studies in gp49B1 Ϫ/Ϫ mice should lead to additional insights into the regulatory functions of NK-IRs.
